Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-14 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-12 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-07 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |